Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 9/20 | 0.46 |
| ▸ | DRD3 | P35462 | 6/20 | 0.46 |
| ▸ | DRD4 | P21917 | 2/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | CCR2 | P41597 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7957582 | 0.91 | OPRL1 (0.45) | DRD2DRD3DRD4OPRL1OPRM1 | |
| SCHEMBL7957071 | 0.83 | DRD2 (0.54) | DRD2DRD3DRD4HTR1AHTR2A | |
| SCHEMBL7949576 | 0.82 | DRD2 (0.48) | DRD2DRD3DRD4HTR1AHTR2A | |
| SCHEMBL7957632 | 0.81 | CCR2 (0.42) | DRD2DRD3DRD4CCR2 | |
| SCHEMBL7961177 | 0.81 | OPRL1 (0.44) | DRD2OPRL1CCR2 | |
| SCHEMBL7949578 | 0.81 | DRD2 (0.46) | DRD2DRD3HTR1AHTR2ACCR2 | |
| SCHEMBL7960161 | 0.80 | CCR2 (0.53) | DRD2DRD3DRD4HTR1AHTR2A | |
| SCHEMBL7949530 | 0.80 | DRD2 (0.56) | DRD2DRD3DRD4 | |
| SCHEMBL7961256 | 0.79 | CCR2 (0.39) | DRD2OPRL1OPRM1OPRK1SLC6A2 | |
| SCHEMBL7959645 | 0.79 | CCR3 (0.42) | DRD2DRD3HTR1AHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187774-B1 | N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0885883-A1 | FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-12-23 | — | — | EP | disclosed |